Eczema cream showdown: which Non-Steroid treatment works best for kids?

NCT ID NCT07519174

Not yet recruiting Disease control Sponsor: Foundation University Islamabad Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two prescription creams, tacrolimus and crisaborole, for treating mild to moderate eczema in children and teens aged 2 to 20. Both creams are steroid-free and aim to control inflammation without the side effects of long-term steroid use. Over 8 weeks, 72 participants will apply one of the creams twice daily, and researchers will measure how much their eczema improves and whether they have any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tacrolimus 0.03% ointment and crisaborole 2% ointment
What this could lead to: If this trial shows one cream is clearly better or safer, it could help doctors choose the best steroid-free option for children with eczema.
What could go wrong: This is a small, early-stage trial with only 72 participants, so results may not apply to everyone. Both creams can cause skin irritation like burning or stinging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

Fauji Foundation Hospital, Rawalpindi

Rawalpindi, Punjab Province, 44000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.